Nautilus Biotechology Up 13% on CNBC Report About Amazon Investment
August 05 2021 - 3:37PM
Dow Jones News
By Josh Beckerman
Nautilus Biotechnology Inc. shares were recently up 13% to $8.46
after CNBC reported that Amazon.com Inc. had invested in the
company.
Amazon had previously disclosed the investment in a Form 13F
filing.
Nautilus was briefly paused due to volatility several times
Thursday. The life sciences company is focused on technology "for
quantifying and unlocking the complexity of the proteome."
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
August 05, 2021 15:36 ET (19:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Apr 2023 to Apr 2024